• Info
  • Insider Ownership

Insider Trading & Ownership of Kristin Abate

Location
Newton, MA
Summary
The estimated net worth of Kristin Abate is at least $207,601 dollars as of 03 Mar 2026. Kristin Abate is the Chief Accounting Officer of Karyopharm Therapeutics Inc. and owns shares of Karyopharm Therapeutics Inc. (KPTI) stock worth about $207.6K.
Signature
/s/ Nancy Smith as Attorney-in-Fact for Kristin Abate
All Insider Reports
All Insider Reports

Notify me when Kristin Abate files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Kristin Abate

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
KPTI Karyopharm Therapeutics Inc. Chief Accounting Officer $207,601 -$10,651 -4.9% 02 Mar 2026

Insider Transactions Reported by Kristin Abate:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.